Messina C,Farad M,de Fazio V,et al.Prevention and treatment of acute GVHD[J].Bone Marrow Transplant,2008,41(Suppl 2):S65-S70.
[2]
Tang Y,Scheef EA,Wang S,et al.CYP1B1expression promotes the proangiogenic phenotype of endothelium through decreased intracellular oxidative stress and thrombospondin-2expression[J].Blood,2008,113(3):744-754.
[3]
Wagner JE,Thompson JS,Carter SL,et al.Effect of graft-versus-host diseaseprophylaxis on 3-year diseasefree survival in recipients of unrelated donor bone marrow(T-cell Depletion Trial):a multi-centre,randomised PhaseⅡ-Ⅲtrial[J].Lancet,2005,366(9 487):733-741.
[4]
Ward JM,Nikolov NP,Tschetter JR,et al.Progressive glomerulonephritis and histiocytic sarcoma associated with macrophage functional defects in CYP1B1-deficient mice[J].Toxicol Pathol,2004,32(6):710-718.
[5]
Cooke KR,Kobzik L,Martin TR,et al.An Experimental Model of Idiopathic Pneumonia Syndrome After Bone Marrow Transplantation:Ⅰ.The Roles of Minor H Antigens and Endotoxin[J].Blood,1996,88(8):3 230-3 239.
[6]
Liu XC,Huang TT,Li L,et al.CYP1B1deficiency ameliorates obesity and glucose intolerance induced by high fat diet in adult C57BL/6Jmice[J].Am J Transl Res,2015,7(4):761-771.